Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
Description | CD19 molecule |
Gene symbol | MS4A1 | Synonyms | B1, Bp35, CD20, CVID5, FMC7, LEU-16, S7 | Type of gene | protein-coding |
Chromosome | 11 | Map location | 11q12.2 | dbXrefs | |
Description | membrane spanning 4-domains A1 |
GTO ID | GTC0352 |
Trial ID | NCT03019055 |
Disease | Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | B-Cell Lymphoma | Non-Hodgkin's Lymphoma |
Altered gene | CD19|CD20 |
Therapeutic/Target gene | Target gene |
Therapy | CAR-T cell |
Treatment | CD19/CD20 CAR-T cells |
Generation | 2nd |
Phase | Phase1 |
Recruitment status | Completed |
Title | Study of CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell |
Year | 2017 |
Country | United States |
Company sponsor | Medical College of Wisconsin |
Other ID(s) | PRO00028724 |
Vector information | |||||||
|
Cohort 1 | |||||||||||||||||
|